Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jun 15;14(6):4015-4023.
eCollection 2022.

Metronidazole-loaded nanoparticulate thermoreversible gel for gynecologic infection of Trichomonas vaginalis

Ling Fang  1 , Xianyi Lu  2 , Chengjun Cui  1 , Qifeng Shi  3 , Haojue Wang  2
Affiliations

Metronidazole-loaded nanoparticulate thermoreversible gel for gynecologic infection of Trichomonas vaginalis

Ling Fang et al. Am J Transl Res. .

Abstract

Objective: Trichomoniasis is a common sexually-transmitted disease that is associated with increased perinatal morbidity and human immunodeficiency virus (HIV) transmission. This study aimed to develop a Metronidazole-loaded nanoparticulate thermoreversible gel for gynecological infection of Trichomonas vaginalis (T. vaginalis).

Methods: The optimized nanoparticulate formulation was used in thermoreversible gel and characterized for physico-chemical properties, antiparasitic activity, and in vivo efficacy in the BALB/c mouse model.

Result: A nearly threefold rise in antiparasitic activity of the optimized formulation was observed as compared to that of regular gel. Formulation F5 successfully cured the trichomoniasis within 3 days, while regular gel and pure Metronidazole (MTDZ) failed to cure this infection (P<0.05).

Conclusion: The present investigation confirms the ability of thermoreversible gel containing nanoparticulate metronidazole againstthe infection by T. vaginalis. The developed gel could be an alternative to the existing drug delivery system for the treatment of trichomoniasis.

Keywords: Metronidazole; Trichomonas vaginalis; chitosan; drug delivery; nanoparticles; poloxamer; thermoreversible; trichomoniasis; vaginal.

PubMed Disclaimer

Conflict of interest statement

None.

Figures

Figure 1
Figure 1
Scanning electron microscopy of nanoparticles.
Figure 2
Figure 2
Permeability of drugs through mucosal membranes. *indicates comparison with F1, #indicates comparison with F2, &indicates comparison with F3, @indicates comparison with F4, P<0.05.
Figure 3
Figure 3
Comparison of infection grading among all groups. *indicates comparison with F5, #indicates comparison with Pure, @indicates comparison with regular gel, P<0.05.
See this image and copyright information in PMC

References

    1. de Barros CHN, Cruz GCF, Mayrink W, Tasic L. Bio-based synthesis of silver nanoparticles from orange waste: effects of distinct biomolecule coatings on size, morphology, and antimicrobial activity. Nanotechnol Sci Appl. 2018;11:1–14. - PMC - PubMed
    1. Vazini H. Anti-trichomonas vaginalis activity of nano Micana cordifolia and Metronidazole: an in vitro study. J Parasit Dis. 2017;41:1034–1039. - PMC - PubMed
    1. Rosenbohm JM, Robson JM, Singh R, Lee R, Zhang JY, Klapperich CM, Pollock NR, Cabodi M. Rapid electrostatic DNA enrichment for sensitive detection of trichomonas vaginalis in clinical urinary samples. Anal Methods. 2020;12:1085–1093. - PMC - PubMed
    1. Fernando HV, Chan LL, Dang N, Santhanes D, Banneheke H, Nalliah S, Coombes AGA. Controlled delivery of the antiprotozoal agent (tinidazole) from intravaginal polymer matrices for treatment of the sexually transmitted infection, trichomoniasis. Pharm Dev Technol. 2019;24:348–356. - PubMed
    1. Schwebke JR, Barrientes FJ. Prevalence of trichomonas vaginalis isolates with resistance to metronidazole and tinidazole. Antimicrob Agents Chemother. 2006;50:4209–4210. - PMC - PubMed

LinkOut - more resources